ACE-031

  • Description
  • Additional information
  • Reviews (0)

Description

Pharmacokinetics 

ACE-031’s mechanism of action rests within blocking chemical signals that inhibit muscle growth. Circulating outside of muscle-fiber membranes, ACE-031 binds to a type of myokine called myostatin. Typically, myostatin limits muscle growth by halting the chemical signals of cells, stopping myogenesis. However, it appears that ACE-031 binds to myostatin, therefore limiting restraining signals and allowing for increased muscle growth.[3]

Scientific Studies

There have been multiple clinical studies on ACE-031, many focused on treating children with Duchenne muscular dystrophy, or DMD. In a study focusing on boys with DMD, ACE-031 was administered once every 2 to 4 weeks. By the end of the study, trends indicating muscle retention and fat loss were noted.[4] Another trial conducted on postmenopausal women also seemed to indicate increased muscle mass.[2]

Sources:

[1] http://investor.acceleronpharma.com/news-releases/news-release-details/acceleron-pharmas-ace-031-increases-muscle-mass-preclinical

[2 ]https://www.ncbi.nlm.nih.gov/pubmed/23169607

[3] https://onlinelibrary.wiley.com/doi/abs/10.1002/mus.23539

[4] https://www.ncbi.nlm.nih.gov/pubmed/27462804

[5] https://www.mda.org/quest/article/update-ace-031-clinical-trials-duchenne-md

Additional information

Weight 23 oz
Dimensions 12 × 31 × 23 in
Color

Black, Blue, Indigo

Size

Large, Medium, Small

Unit Size

10

Unit Quantity

10

CAS

text

Formula

text

Molecular weight

value

Sequence

text

Appearance

text

Peptide Purity

text

Solubility

text

Source

text

Storage

text

WARNING

text

Reviews

There are no reviews yet.


Be the first to review “ACE-031”

You've just added this product to the cart: